Job attributes, job satisfaction and the return to health after breast cancer diagnosis and treatment by Barnes, Andrew J. et al.
Virginia Commonwealth University
VCU Scholars Compass
Healthcare Policy and Research Publications Dept. of Healthcare Policy and Research
2014
Job attributes, job satisfaction and the return to
health after breast cancer diagnosis and treatment
Andrew J. Barnes
Virginia Commonwealth University, abarnes3@vcu.edu
Nicholas Robert
US Oncology Network
Cathy J. Bradley
Virginia Commonwealth University, cjbradley@vcu.edu
Follow this and additional works at: http://scholarscompass.vcu.edu/hcpr_pubs
Part of the Medicine and Health Sciences Commons
Copyright © 2013 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Barnes, A. J.,
Robert, N. and Bradley, C. J. (2014), Job attributes, job satisfaction and the return to health after breast cancer diagnosis
and treatment. Psycho-Oncology, 23: 158–164, which has been published in final form at http://dx.doi.org/10.1002/
pon.3385. This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for
self-archiving.
This Article is brought to you for free and open access by the Dept. of Healthcare Policy and Research at VCU Scholars Compass. It has been accepted
for inclusion in Healthcare Policy and Research Publications by an authorized administrator of VCU Scholars Compass. For more information, please
contact libcompass@vcu.edu.
Downloaded from
http://scholarscompass.vcu.edu/hcpr_pubs/3
1 
 
Job attributes, job satisfaction and the return to health after breast cancer diagnosis and treatment 
 
Andrew J.  Barnes, M.P.H., Ph.D.1 
Nicholas Robert, M.D.2 
Cathy J. Bradley, Ph.D.1,3 
 
1Department of Healthcare Policy and Research 
Virginia Commonwealth University School of Medicine 
2 U.S. Oncology Network 
3Virginia Commonwealth University Massey Cancer Center 
 
Corresponding Author: 
Andrew James Barnes, Ph.D. 
Assistant Professor 
Department of Healthcare Policy and Research 
VCU School of Medicine 
P.O. Box 980430  
Richmond, VA 23298-0430 
Phone: (804) 827-4361 
Fax : (804) 628-1233 
Email: abarnes3@vcu.edu 
 
Running head: Job attributes & breast cancer treatment 
Manuscript word count: 2,777 
Abstract word count: 236 
Text pages including title page: 13 
Tables: 3 
Figures: 0 
Key words: chemotherapy, breast cancer, occupation, job attributes, job satisfaction, mental 
health  
 
This is the peer reviewed version of the following article: Barnes, A. J., Robert, N. and Bradley, 
C. J. (2014), Job attributes, job satisfaction and the return to health after breast cancer diagnosis 
and treatment. Psycho-Oncology, 23: 158–164, which has been published in final form at 
http://dx.doi.org/10.1002/pon.3385.  This article may be used for non-commercial purposes in 
accordance with Wiley Terms and Conditions for self-archiving.  
2 
 
Abstract 
Background: As detection and treatment of cancer has advanced, the number of working age 
women with breast cancer has increased. This study provides new information on the intersection 
of breast cancer treatment and job tasks and how, together, they impact employed and newly 
diagnosed women.  
Methods: The sample comprised 493 employed women within two months of initiating 
treatment.  Job satisfaction and demands were assessed by pre-diagnosis recall along with 
measures of mental and physical health and assessed again nine months after initiating treatment.  
Using seemingly unrelated regression, we tested the effect of job tasks and satisfaction on mental 
and physical health nine months post-treatment initiation, controlling for pre-diagnosis health 
status, patient characteristics, and job tasks.  
Results: Physical job demands prior to diagnosis were not significantly associated with mental or 
physical health nine months after treatment initiation. Employment in cognitively demanding and 
less satisfying jobs was associated with decreases in mental health and increases in problems 
with work or daily activities nine months post-treatment initiation (p<0.05). Women who 
received five or more cycles of chemotherapy reported lower vitality, social functioning, and 
worse measures of physical health compared to those who did not receive chemotherapy 
(p<0.05).  
Conclusions: Employment in cognitively demanding and unsatisfying jobs may impede mental 
health recovery, particularly in patients who receive longer chemotherapy regimens. Such 
information may be used by patients and clinicians in deciding when to undergo chemotherapy 
and whether job tasks can be restructured to hasten recovery.  
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Introduction 
As the detection of and treatment for cancer have advanced, the number of working age 
women with breast cancer has increased [1].  For both personal and financial reasons, many 
employed women remain attached to their jobs during treatment and desire to return to their jobs 
once treatment is complete. Outpatient chemotherapy and radiation are often managed such that 
many employed women work throughout treatment. In a seminal call to action, the Institute of 
Medicine highlighted employed cancer survivors’ need for interventions to minimize the 
negative impact of cancer and its treatment on survivors’ workplace performance [2]. Yet, little 
is known about how treatment type and job characteristics influence patients’ health and 
successful return to work, creating challenges for effective interventions. 
 This study provides new information on the intersection of treatment and job attributes 
and how they impact the physical and mental well-being of employed women newly diagnosed 
with breast cancer. Women who require several months of chemotherapy and/or radiation 
experience greater work interruption than women treated with surgery alone. These women are 
more likely to go on disability, stop working, or retire relative to women who did not receive 
chemotherapy [3]. The side effects of chemotherapy, which include pain, fatigue, and memory 
changes, among others, can continue for several months or even years following the completion 
of treatment [3-5].  Nonetheless, cancer patients with strong commitments to their work 
organization or a good social climate at work report less mental and physical impairment [1, 6-
7]. In addition, a wide work-related social network is associated with fewer depressive symptoms 
among women with cancer [7].  However, how the combination of treatment, job tasks, and job 
satisfaction are correlated with employed women’s recovery has not been investigated. A more 
complete understanding of these associations may improve patient and provider decision-making 
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regarding chemotherapy as well as lead to interventions that can minimize cancer’s negative 
workplace consequences and a more expeditious recovery from treatment.  
Methods 
Sample 
We enrolled 625 employed women diagnosed with breast cancer within two months of 
initiating treatment with intent to cure. To obtain this sample, we collaborated with three 
hospital-based treatment centers and five private oncology centers from urban and rural areas 
within Virginia. Inclusion criteria were: between age 21 and 64 years, employed, and because 
this study was part of a larger study that aimed to study the impact of health insurance on work 
outcomes, women had to be insured either through their employer or through a spouse’s 
employer, if married. The original study was powered to detect statistically significant 
differences in weekly hours worked between married women insured by their employer and 
those insured by their spouse’s employer.  Therefore, the study sample has a disproportionate 
number of married women.  
Study notification letters were mailed to potentially eligible patients’ physicians; four 
physicians refused contact.  Interviewers telephoned women to further screen for eligibility 
(n=1,001). Of these, 17.9% of women refused to participate; 10.5% were ineligible for the study; 
and 8.8% could not be contacted.  We interviewed 625 women via telephone at three time points: 
1) at baseline, where patients were asked to describe their employment situation and health status 
prior to diagnosis, 2) within two months following surgery or the  initiation chemotherapy or 
radiation, and 3) nine months after initiating treatment. The questionnaires asked information 
about patients’ demographic characteristics, job attributes, job satisfaction, and mental and 
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physical health status. In addition to the telephone interview, we conducted audits of patients’ 
medical records. These audits extracted information about cancer stage, surgery, chemotherapy 
regimen, and radiation. Of the 625 women in our sample, 123 were either deceased, too ill to 
continue, had cancers that had metastasized, or stopped working before the final interview.  Of 
the remaining 502 women, the analytic sample included 493 (79% of those interviewed) with 
complete outcomes, job attributes, and job satisfaction data.   
Mental and physical health outcomes 
Mental and physical health measures were assessed at baseline and nine months after 
initiating treatment. At baseline, patients recalled their mental and physical health status just 
prior to diagnosis. Twelve mental and physical health outcomes were derived from responses to 
the SF-36v2 Health Survey and the 10-item Center for Epidemiologic Studies Depression scale 
(CESD-10) [8-9].The SF-36v2 Health Survey was scored using QualityMetric’s Health 
Outcomes Scoring Software, version 4.5.1 with the Mental Health Enhanced feature.  Eight 
domain t-scores (vitality, social functioning, role-emotional, general mental health, physical 
functioning, role-physical, bodily pain, general physical health), the mental and physical 
component scores (MCS and PCS), and the mental health severity (MHS) score approximates the 
Beck Depression Inventory (BDI) [10]. The CESD-10 summary score at nine months following 
treatment initiation was used as an additional measure of depressive symptoms. 
Job attributes 
Patients were asked whether their job required them to do the following eight tasks “none 
or almost none of the time,” “some of the time,” “most of the time,” or “all or almost all of the 
time:” (1) physical effort, (2) lifting heavy loads, (3) stooping, kneeling, or crouching, (4) intense 
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concentration or attention, (5) analyze data or information, (6) keep up with the pace set by 
others, (7) learn new things, and (8) have good eyesight. These questions are identical to those 
used by the Health and Retirement Survey [11]. Response codes ranged from 1 to 4 with higher 
numbers representing increased task performance. To uncover patterns in variation across the 
eight job attribute items and thereby potentially combine several of the original measures, we 
used exploratory factor analysis. Items (1)-(3) loaded onto a factor representing physical job 
demands (Eigenvalue =1.71, all three items loaded 0.7 or higher) while items (4) – (8) loaded 
onto a factor representing cognitive demands (Eigenvalue =1.43, items loaded between 0.38 for 
eyesight and 0.63 for concentration).  We estimated an unweighted average of items (1) – (3) as 
the physical demand measure and an unweighted average of items (4) – (8) as the cognitive 
demand measure. The cognitive and physical demand measures were internally consistent with 
Cronbach’s alphas of 0.82 and 0.66, respectively.  
Job satisfaction 
We assessed job satisfaction at baseline using the 20-item short form of the Minnesota 
Satisfaction Questionnaire (MSQ) [12-13]. Responses to each item were on a five point Likert 
scale with higher numbers representing more satisfaction (i.e., not satisfied, somewhat satisfied, 
satisfied, very satisfied, extremely satisfied).  An unweighted average of responses to the 20 job 
satisfaction items was included in our analysis. 
Covariates 
Baseline measures of mental and physical health were included in all estimations to 
adjust for pre-diagnosis physical and mental health. Educational attainment was categorized as 
high school or less, some college, bachelor’s degree, and advanced degree. Demographic 
7 
 
characteristics included age, race/ethnicity (patient self-reported as non-Hispanic African 
American, other race/ethnicity, or non-Hispanic White), marital status, having children under age 
18, and annual household income of less than $40,000, $40,000-$74,999, $75,000-$150,000, and 
$150,000 or more.  Employer-level controls included type of industry (government, private for-
profit, private non-profit, and self-employed); and size of employer (less than 25, 25-49, 50-99, 
and 100 or more employees).  
We included an indicator for whether the patient received only radiation treatment 
between the baseline interview and the nine-month interview and, for those receiving 
chemotherapy, indicators for chemotherapy regimens of 1 to 4 cycles or 5 or more cycles.  
Indicators representing whether the patient received hormone therapy and Herceptin treatment 
were also included separately in our model.  A dummy variable for whether the patient was still 
in treatment at the time of the nine-month interview was also included.  Most women had 
completed treatment (79.9%).  Of the 493 women in the analytic sample, missing data indicators 
were added as covariates to include the 3.3% of our sample missing the treatment indicator for 
nine months and the 2.2% who were missing income information. 
Statistical analysis 
Mental and physical health outcomes are closely related. Therefore, we allow for 
covariance between error terms of the equations by jointly estimating a system of 12 linear 
regressions using a generalized least squares estimator (i.e., Zellner’s seemingly unrelated 
regression [SUR] [14]), which is more efficient than estimating these equations separately [15]. 
SUR allows for joint Chi-square tests of significance of job attribute and satisfaction coefficients 
across sets of mental and physical health outcomes [15]. The Breusch-Pagan test rejected the 
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hypothesis that the error terms in the 12 equations were independent (p<0.05) confirming that 
estimating the system of regressions simultaneously with correlation among the error terms was 
appropriate. Statistical significance was determined at the 5 percent level.  
Role of the funder: The funding source had no involvement in the study design, data collection, data 
analysis, or in writing the paper 
Results 
Sample characteristics 
Women were, on average, 49 years old. The majority of women had at least a college 
education (59.3%), were married (78.9%), did not have children under age 18 (61.3%), were 
non-Hispanic White (83.6%) and resided in households earning $75,000 or more per year 
(69.4%) (Table 1).  About half of the women worked in private, for-profit firms (47.0%) and 
72.8% worked in businesses with 100 or more employees.  Women reported a baseline physical 
job demand score of 1.71 (SD 0.77) suggesting that their jobs required physical effort, lifting 
heavy loads, and stooping, kneeling and crouching approximately “some of the time.” The 
average baseline cognitive demand score of 3.11 (SD 0.59) suggested that women’s jobs 
required intense concentration or attention, analyzing data or information, keeping up with the 
pace set by others, learning new things, and good eyesight “most of the time.” The majority of 
women were satisfied, very satisfied or extremely satisfied with their job.  The average woman 
reported a job satisfaction score of 3.36 (SD 0.60). Most (72.8%) received radiation or hormone 
(62.3%) therapy between baseline and nine months after initiating treatment while 16.6% and 
51.1% of women received 2 to 4 cycles or 5 or more cycles of chemotherapy, respectively.  Few 
women were on Herceptin (15.8%) or were receiving treatment at the nine month interview 
(16.8%). 
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Women reported, on average, physical and mental health prior to diagnosis above the 
U.S. population (Table 2). The mean baseline MHS and CESD-10 scores were 5.09 (standard 
deviation (SD) 5.25) and 4.12 (SD 4.80) respectively, suggesting that the average woman did not 
experience depressive symptoms before diagnosis. However, by nine months after treatment 
initiation, mental and physical health deteriorated (p<0.05). The average MHS and CESD-10 
scores increased to 6.14 (SD 5.35) and 6.05 (SD 5.49) (p<0.05), respectively, but remained 
below the threshold for mild depressive symptoms (CESD-10 score of 10 or more) [9].  
Adjusted associations of job attributes, job satisfaction and mental and physical health 
Mental health and depression nine months after treatment initiation 
Physical job demands pre-diagnosis were not significantly associated with mental health 
measures nine-months after treatment initiation. Cognitive job demands were negatively 
associated with mental health outcomes nine months after treatment initiation (joint Chi-square 
test 13.98, p=0.05). Increasing whether a woman’s job pre-diagnosis required cognitive tasks 
“some of the time” to “most of the time” was associated with a 2.25 point decline in vitality, a 
1.74 decrease in social functioning and  a 1.27 point decline in mental component score (MCS) 
(p<0.05 each, Table 3, full model results in Appendix 1).  To put the effect sizes of occupational 
attributes on health outcomes among these patients into perspective, a recent study found breast 
cancer survivors’ MCS score declined 2.9 points after diagnosis and treatment compared to age 
matched controls [16].   
Job satisfaction was positively correlated with mental health measures (joint Chi-square 
test 14.66, p<0.05). Increasing job satisfaction from, for example, “somewhat satisfied” to 
“satisfied” was associated with increases in vitality (2.52 points, p<0.05) and general mental 
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health (2.59 points, p<0.05). Likewise, job satisfaction was associated with increases in MCS 
(2.32 points) and decreases in MHS (1.61 points) and CESD-10 measures of depressive 
symptoms (1.16) (p<0.05 each).  Receiving radiation therapy, hormone treatment, and Herceptin 
were not associated with mental health outcomes.  However, receiving chemotherapy for 2 to 4 
cycles was associated with decreases in social functioning (2.70 points) and chemotherapy 
regimens of 5 or more cycles was associated with decreases in vitality (2.69 points) (p<0.05 
each). 
Physical health nine months after treatment initiation 
Physical job demands were not significantly associated with physical health nine months 
after treatment initiation.  Cognitively demanding occupations were associated with patients 
reporting increased problems at work or with other social activities due to physical health (role-
physical) and with decreases in overall physical health (PCS). Shifting cognitive demands, on 
average, from “some of the time” to “most of the time” was associated with a decrease in role-
physical (1.93, p<0.05) and weakly associated with decreases in PCS (1.23, p<0.10) (Table 3).  
Relative to surgery alone, chemotherapy was associated with declines in physical functioning 
(2.53 points for 2 to 4 cycles, 3.36 points for 5 or more cycles), role-physical (3.24 points for 5 
or more cycles), bodily pain (2.61 points for 5 or more cycles), general health (2.51 points for 5 
or more cycles), and PCS (2.67 points for 2 to 4 cycles, 3.94 points for 5 or more cycles) (p<0.05 
each).  
Discussion 
Approximately 40% to 60% of all cancer survivors are employed when diagnosed [17]. 
An important part of successful survivorship for many is return to work at prior capacity. Our 
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study finds new evidence that cognitive job demands and job satisfaction prior to diagnosis 
influence survivors’ ability to return to their pre-diagnosis mental and physical level of 
functioning.  Greater job satisfaction prior to diagnosis had a positive influence on mental 
recovery.  This evidence suggests that employees’ beliefs and affective experiences about their 
work tasks and the workplace have an important role in the recovery of employed patients; poor 
job satisfaction prior to treatment initiation may be harbinger of slow recovery. 
The effect of cognitive job demands also had considerable influence among women. 
Women in cognitively demanding jobs who had prolonged chemotherapy experienced declines 
in physical and mental health including measures of vitality, social functioning and problems at 
work due to physical health. Several recent studies highlight the increased risk of cognitive 
impairment associated with chemotherapy (e.g. “chemobrain”) [18-19]. Women on 
chemotherapy for prolonged duration may find it more difficult to return to their former capacity 
and may become frustrated with their perceived inability to perform at the same level. For 
women whose cognitive demands cannot be changed or who are highly committed to cognitively 
demanding occupations, the long-term therapeutic benefit of chemotherapy should, therefore, be 
evaluated alongside the mental and physical decrements resulting from such treatment. 
Alternatively, reducing a patient’s cognitive job demands, when possible, may mitigate adverse 
physical and mental health consequences associated with chemotherapy.  In either case, our 
results imply patients and providers should discuss the extent to which job tasks are mutable in 
making chemotherapy decisions. 
The study has five limitations.  First, the sample was not randomly selected and instead 
selected from employed patients treated at several oncology practices within a single state.  
Therefore, caution should be taken when generalizing the findings. Nonetheless, there is little 
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reason to believe employed breast cancer patients vary in the outcomes we study. Second, 
occupational attributes and health measures were self-reported and refer to the time period before 
diagnosis. Prior evidence suggests cancer patients tend to overstate their pre-diagnosis health 
status [20].  To the extent pre-diagnosis mental and physical health were similarly biased 
upwards, the regression estimates reported may understate the association between pre-diagnosis 
job demands and satisfaction and post-treatment health status. Third, the follow-up interview was 
nine months following treatment initiation, which may not be reflective of long-term recovery 
and return to functioning. Thus, patients receiving fewer cycles of chemotherapy would have 
more time to recover by the nine-month post-treatment interview than women receiving more 
cycles of treatment. However, the majority of women receiving 5 or more cycles of 
chemotherapy had completed treatment 20 weeks or more prior to the nine-month interview 
whereas those who had fewer cycles completed treatment 27 weeks prior to the nine-month 
interview.  Furthermore, our nine-month follow-up period limits our results to short-run 
associations between job attributes and health following diagnosis of and treatment for breast 
cancer.  Nonetheless, prior research using a 2-6 year recall period has found that, compared to 
healthy controls, cancer survivors report lower levels of energy and mental resilience while 
working, poorer physical and mental work ability, and worse physical and mental health [21].  
Fourth, our analysis allows us to estimate the adjusted associations between job demands, job 
satisfaction, and health outcomes.  We cannot infer a causal relationship from our modeling 
approach. Lastly, the sample includes only those who remained at work. The exclusion of 
women who stopped working in our sample is likely to bias the results towards the null given 
that women who were unable to remain working may have been in worse health and in more 
demanding occupations than those who remained employed. Indeed, prior evidence suggests 
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cancer survivors in occupations that are more physically straining have more difficulty returning 
to work after diagnosis and treatment [22]. 
This study provides new evidence that cognitive job attributes and job satisfaction 
influence health status following breast cancer treatment.  Although our study provides 
preliminary evidence of the short-term associations of job attributes and health following cancer 
treatment, if confirmed by subsequent studies, a practical implication of this research is the need 
to prospectively evaluate a new patient who is a candidate for adjuvant chemotherapy regarding 
her work environment. Knowing this information provides clinicians an opportunity to advise 
patients in deciding whether to undergo chemotherapy when employed in a cognitively 
demanding job or whether job tasks and work flow can be restructured to increase patients’ 
tolerance of chemotherapy.  This latter implication also suggests that workplace interventions to 
increase women with breast cancers’ ability to return to pre-treatment employment levels should 
be explored and evaluated.  
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Table 1. Sample characteristics (n=493) 
Variable Pre-diagnosis 
Job attributes, Mean (SD)  
  Physical  1.71 (0.77) 
  Cognitive  3.11 (0.59) 
  Job satisfaction 3.36 (0.60) 
Cancer Treatment  
  Radiation  72.8% 
  Hormone therapy 62.3% 
  Chemotherapy treatment   
    2 to 4 cycles 16.6% 
    5 or more cycles 51.1% 
  Herceptin 15.8% 
  In treatment at nine-month interview 16.8% 
  Missing in treatment at nine months 3.3% 
Age in years, Mean (SD) 48.99 (7.64) 
Educational attainment  
  High school degree or less 13.2% 
  Some college or AA degree 27.5% 
  Bachelor’s degree 32.9% 
  Advanced degree 26.4% 
Household structure  
  Not married 21.1% 
  Have children under age 18 38.7% 
  Annual Household Income   
    < $40,000 8.7% 
    $40,000-$74,999 21.3% 
    $75,000-$149,000 47.5% 
    $150,000 or more 20.3% 
    Missing income 2.2% 
Race/Ethnicity  
  Non-Hispanic White 83.6% 
  Non-Hispanic African American 13.8% 
  Other  2.6% 
Type of industry  
  Government 34.9% 
  Private, for-profit 47.0% 
  Private, non-profit 13.0% 
  Self-employed 5.1% 
Number of employees  
  Under 25 16.6% 
  25-49 5.1% 
  50-99 5.5% 
  100 or more 72.8% 
Notes: SD=Standard deviation; CESD-10=10 item Center for Epidemiologic Studies Depression scale 
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Table 2. Physical and mental health pre-diagnosis and 9 months after initiating treatment 
(n=493) 
Variable Pre-diagnosis 9-months 
post-tx 
initiation 
t-test p-value 
SF-36v2   
 Domain t-scores, Mean 
(SD) 
    
   Physical functioning 54.96 (4.74) 49.62 (8.31) 15.06 <0.01 
   Role-physical 55.02 (5.12) 48.66 (8.81) 15.94 <0.01 
   Bodily pain 56.55 (8.07) 49.23 (9.49) 15.11 <0.01 
   General physical health 56.95 (8.60) 51.64 (9.55) 12.64 <0.01 
   Vitality  55.24 (8.73) 49.08 (9.36) 13.59 <0.01 
   Social functioning  53.62 (6.81) 49.21 (9.85) 9.75 <0.01 
   Role-emotional 53.54 (6.16) 50.77 (8.16) 7.55 <0.01 
   General mental health 53.89 (8.30) 52.13 (8.44) 4.26 <0.01 
  Summary measures    <0.01 
   Mental component score 53.12 (8.13) 51.24 (8.91) 4.52 <0.01 
   Physical component score 56.27 (5.73) 48.89 (8.86) 18.78 <0.01 
   Mental health severity 5.09 (5.25) 6.14 (5.35) -3.97 <0.01 
CESD-10 4.12 (4.80) 6.05 (5.49) -7.72 <0.01 
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Table 3. Adjusted associations of job attributes and job satisfaction with physical health and mental health outcomes (n=493) 
Physical and Mental 
Health Outcomes 
Physical job 
demands 
β 
(95% CI) 
Cognitive job 
demands 
β 
(95% CI) 
Job satisfaction 
 
β 
(95% CI) 
Up to 4 cycle of 
chemotherapy 
5 or more cycles 
of chemotherapy 
SF 36 domains      
  Physical functioning -- -- -- -2.53** 
(-4.46, -.059) 
-3.36*** 
(-4.94, -1.79) 
  Role-physical -- -1.93***  
(-3.22, -0.63) 
1.67 * 
(-0.05, 3.40) 
-1.91* 
(-4.10, 0.28) 
-3.24*** 
(-5.02, -1.46) 
  Bodily pain -- -- -- -- -2.62** 
(-4.53, -0.71) 
  General physical  
  health 
-- -- -- -1.90* 
(-4.13, -0.07) 
-2.51** 
(-4.32, -0.70) 
  Vitality -- -2.25***  
(-3.57, -0.92) 
2.52**  
(0.76, 4.29) 
-2.00* 
(-4.25, 0.26) 
-2.59** 
(-4.42, -0.76) 
  Social functioning -- -1.74**  
(-3.18, -0.30) 
-- -2.70** 
(-5.14, -0.26) 
-1.72* 
(-3.71, 0.26) 
  Role-emotional -- -1.08*  
(-2.25, 0.10) 
-- -- -- 
  General mental health -- -- 2.59***  
(1.00, 4.19) 
-- -- 
Physical component 
score 
-- -1.23*  
(-2.48, 0.02) 
-- -- -2.67** 
(-4.78, -0.57) 
Mental component 
score 
-- -1.27**  
(-2.54, 0.00) 
2.33** 
(0.64, 4.01) 
-- -- 
Mental health severity -- -- -1.61***  
(-2.64, -0.58) 
-- -- 
CESD-10 -- 0.73* 
(-0.05, 1.51) 
-1.16**  
(-2.20, -0.12) 
-- -- 
Notes: Non significant results shown as “--“, full model results shown in Appendix 1.* p<0.10, **p<0.05, ***p<0.01. All models were estimated with seemingly 
unrelated regression adjusted for whether the patient received radiation , hormone therapy, Herceptin, age, education, marital status, having children under age 
18, annual household income, type of firm, size of firm, and physical and mental health status prior to diagnosis. Breusch-Pagan test of independence of error 
terms Chi-square = 8,754.11, p<0.01.  CESD-10=10 item Center for Epidemiologic Studies Depression scale.  
